177 related articles for article (PubMed ID: 30885978)
21. Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin.
Dalva-Aydemir S; Bajpai R; Martinez M; Adekola KU; Kandela I; Wei C; Singhal S; Koblinski JE; Raje NS; Rosen ST; Shanmugam M
Clin Cancer Res; 2015 Mar; 21(5):1161-71. PubMed ID: 25542900
[TBL] [Abstract][Full Text] [Related]
22. Regulatory Role of Hexokinase 2 in Modulating Head and Neck Tumorigenesis.
Li WC; Huang CH; Hsieh YT; Chen TY; Cheng LH; Chen CY; Liu CJ; Chen HM; Huang CL; Lo JF; Chang KW
Front Oncol; 2020; 10():176. PubMed ID: 32195170
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of Gene Expression of Hexokinases in Colorectal Cancer with the Use of Bioinformatics Methods].
Krasnov GS; Dmitriev AA; Sadtritdinova AF; Fedorova MS; Snezhkina AV; Melnikova NV; Poteryakhina AV; Nyushko KM; Belyakov MM; Kaprin AD; Zaretsky AR; Kudryavtseva AV
Biofizika; 2015; 60(6):1050-6. PubMed ID: 26855992
[TBL] [Abstract][Full Text] [Related]
24. Hexokinase 2 is a determinant of neuroblastoma metastasis.
Botzer LE; Maman S; Sagi-Assif O; Meshel T; Nevo I; Yron I; Witz IP
Br J Cancer; 2016 Mar; 114(7):759-66. PubMed ID: 26986252
[TBL] [Abstract][Full Text] [Related]
25. Hexokinase 2 as a novel selective metabolic target for rheumatoid arthritis.
Bustamante MF; Oliveira PG; Garcia-Carbonell R; Croft AP; Smith JM; Serrano RL; Sanchez-Lopez E; Liu X; Kisseleva T; Hay N; Buckley CD; Firestein GS; Murphy AN; Miyamoto S; Guma M
Ann Rheum Dis; 2018 Nov; 77(11):1636-1643. PubMed ID: 30061164
[TBL] [Abstract][Full Text] [Related]
26. Hexokinase II may be dispensable for CD4 T cell responses against a virus infection.
Varanasi SK; Jaggi U; Hay N; Rouse BT
PLoS One; 2018; 13(1):e0191533. PubMed ID: 29352298
[TBL] [Abstract][Full Text] [Related]
27. Linker residues regulate the activity and stability of hexokinase 2, a promising anticancer target.
Ferreira JC; Khrbtli AR; Shetler CL; Mansoor S; Ali L; Sensoy O; Rabeh WM
J Biol Chem; 2021; 296():100071. PubMed ID: 33187984
[TBL] [Abstract][Full Text] [Related]
28. MiR-216a-5p/Hexokinase 2 axis regulates uveal melanoma growth through modulation of Warburg effect.
Liu Y; Huo Y; Wang D; Tai Y; Li J; Pang D; Zhang Y; Zhao W; Du N; Huang Y
Biochem Biophys Res Commun; 2018 Jul; 501(4):885-892. PubMed ID: 29763606
[TBL] [Abstract][Full Text] [Related]
29. Hexokinase-2 depletion inhibits glycolysis and induces oxidative phosphorylation in hepatocellular carcinoma and sensitizes to metformin.
DeWaal D; Nogueira V; Terry AR; Patra KC; Jeon SM; Guzman G; Au J; Long CP; Antoniewicz MR; Hay N
Nat Commun; 2018 Jan; 9(1):446. PubMed ID: 29386513
[TBL] [Abstract][Full Text] [Related]
30. Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts.
Littlejohn JE; Cao X; Miller SD; Ozvaran MK; Jupiter D; Zhang L; Rodarte C; Smythe WR
Int J Cancer; 2008 Jul; 123(1):202-8. PubMed ID: 18360826
[TBL] [Abstract][Full Text] [Related]
31. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
Hui L; Zhang J; Guo X
Biomed Pharmacother; 2018 Jul; 103():1194-1201. PubMed ID: 29864898
[TBL] [Abstract][Full Text] [Related]
32. c-Src phosphorylation and activation of hexokinase promotes tumorigenesis and metastasis.
Zhang J; Wang S; Jiang B; Huang L; Ji Z; Li X; Zhou H; Han A; Chen A; Wu Y; Ma H; Zhao W; Zhao Q; Xie C; Sun X; Zhou Y; Huang H; Suleman M; Lin F; Zhou L; Tian F; Jin M; Cai Y; Zhang N; Li Q
Nat Commun; 2017 Jan; 8():13732. PubMed ID: 28054552
[TBL] [Abstract][Full Text] [Related]
33. Elevated Heme Synthesis and Uptake Underpin Intensified Oxidative Metabolism and Tumorigenic Functions in Non-Small Cell Lung Cancer Cells.
Sohoni S; Ghosh P; Wang T; Kalainayakan SP; Vidal C; Dey S; Konduri PC; Zhang L
Cancer Res; 2019 May; 79(10):2511-2525. PubMed ID: 30902795
[TBL] [Abstract][Full Text] [Related]
34. Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway.
Wu H; Pan L; Gao C; Xu H; Li Y; Zhang L; Ma L; Meng L; Sun X; Qin H
Molecules; 2019 May; 24(10):. PubMed ID: 31137633
[TBL] [Abstract][Full Text] [Related]
35. PGC1β regulates multiple myeloma tumor growth through LDHA-mediated glycolytic metabolism.
Zhang H; Li L; Chen Q; Li M; Feng J; Sun Y; Zhao R; Zhu Y; Lv Y; Zhu Z; Huang X; Xie W; Xiang W; Yao P
Mol Oncol; 2018 Sep; 12(9):1579-1595. PubMed ID: 30051603
[TBL] [Abstract][Full Text] [Related]
36. Fubp1 supports the lactate-Akt-mTOR axis through the upregulation of Hk1 and Hk2.
Kang M; Lee SM; Kim W; Lee KH; Kim DY
Biochem Biophys Res Commun; 2019 Apr; 512(1):93-99. PubMed ID: 30871777
[TBL] [Abstract][Full Text] [Related]
37. Metformin induces autophagy and G0/G1 phase cell cycle arrest in myeloma by targeting the AMPK/mTORC1 and mTORC2 pathways.
Wang Y; Xu W; Yan Z; Zhao W; Mi J; Li J; Yan H
J Exp Clin Cancer Res; 2018 Mar; 37(1):63. PubMed ID: 29554968
[TBL] [Abstract][Full Text] [Related]
38. PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer.
Yang T; Ren C; Qiao P; Han X; Wang L; Lv S; Sun Y; Liu Z; Du Y; Yu Z
Oncogene; 2018 Nov; 37(45):5997-6009. PubMed ID: 29985480
[TBL] [Abstract][Full Text] [Related]
39. Expression of hexokinase 1 and hexokinase 2 in mammary tissue of nonlactating and lactating rats: evaluation by RT-PCR.
Kaselonis GL; McCabe ER; Gray SM
Mol Genet Metab; 1999 Nov; 68(3):371-4. PubMed ID: 10562464
[TBL] [Abstract][Full Text] [Related]
40. CDK8 Selectively Promotes the Growth of Colon Cancer Metastases in the Liver by Regulating Gene Expression of TIMP3 and Matrix Metalloproteinases.
Liang J; Chen M; Hughes D; Chumanevich AA; Altilia S; Kaza V; Lim CU; Kiaris H; Mythreye K; Pena MM; Broude EV; Roninson IB
Cancer Res; 2018 Dec; 78(23):6594-6606. PubMed ID: 30185549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
